JP2000037450A - Adhesion preventive material and its manufacture - Google Patents

Adhesion preventive material and its manufacture

Info

Publication number
JP2000037450A
JP2000037450A JP10205646A JP20564698A JP2000037450A JP 2000037450 A JP2000037450 A JP 2000037450A JP 10205646 A JP10205646 A JP 10205646A JP 20564698 A JP20564698 A JP 20564698A JP 2000037450 A JP2000037450 A JP 2000037450A
Authority
JP
Japan
Prior art keywords
adhesion
film
gelatin
adhesion preventing
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10205646A
Other languages
Japanese (ja)
Other versions
JP3517358B2 (en
Inventor
Chiyokushin Se
直心 施
Shojiro Matsuda
晶二郎 松田
Hiroo Iwata
博夫 岩田
Yoshito Ikada
義人 筏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JMS Co Ltd
Gunze Ltd
Original Assignee
JMS Co Ltd
Gunze Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JMS Co Ltd, Gunze Ltd filed Critical JMS Co Ltd
Priority to JP20564698A priority Critical patent/JP3517358B2/en
Publication of JP2000037450A publication Critical patent/JP2000037450A/en
Application granted granted Critical
Publication of JP3517358B2 publication Critical patent/JP3517358B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide an adhesion preventive material excellent in adhesion to living tissue and showing a high water content and high glucose permeability and having biological absorbability and appropriate absorption rate. SOLUTION: A 10% aqueous solution is prepared by dissolving gelatin in water, is flow cast on a glass sheet made water-repellent, and is dried to obtain a film that is about 100 μm thick. Next, a sterilizing ultraviolet lamp is used to irradiate the gelatin film obtained with ultraviolet irradiation of 15 watts at a distance of 60 cm for ten hours to obtain an adhesion preventive material.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、生体組織同士の癒
着を防止する癒着防止材及びその製造方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an adhesion preventing material for preventing adhesion between living tissues and a method for producing the same.

【0002】[0002]

【従来の技術】外科手術後には、しばしば生体組織同士
の癒着が発生し、痛みや機能障害を引き起こすが、癒着
は産婦人科、消化器外科、整形外科および心臓外科分野
においてとくに問題となり、ひどい場合は癒着を剥離す
るための手術が必要になる。また、癒着のため、原疾患
の再手術が困難であることが多い。この癒着を防止する
ために、癒着の発生する恐れのある部位を膜で隔離する
方法があり、一部で使用されている。
2. Description of the Related Art After surgery, adhesions between living tissues often occur, causing pain and dysfunction. However, adhesions are particularly problematic in the fields of obstetrics and gynecology, gastroenterological surgery, orthopedic surgery and cardiac surgery, and are severe. If so, surgery to remove the adhesions will be required. In addition, due to adhesion, it is often difficult to perform a reoperation for the primary disease. In order to prevent this adhesion, there is a method of isolating a site where an adhesion may occur with a membrane, and some methods are used.

【0003】[0003]

【発明が解決しようとする課題】このような癒着防止法
に現在使用されている材料としては、酸化セルロース膜
やヒアルロン酸・カルボキシルメチルセルロース混合膜
があるが、その効果は極めて不充分で、限られた症例に
使用されているにすぎない。本発明者らは、酸化セルロ
ース膜の癒着防止効果が不充分な理由について種々検討
を行った結果、以下に述べる2つ問題点があることが判
明した。すなわち、第1の問題点は、膜が生体に充分に
固定されず、当初の位置から動いてしまうことである。
そのため、癒着防止が必要な部位で遮蔽効果が発揮され
ないことになる。これに対して、膜を確実に固定する方
法として接着剤による接着や縫合糸による縫合が考えら
れるが、酸化セルロース膜は強度が弱いために、これら
の方法で固定するのは困難である。また、たとえこのよ
うな方法で固定できたとしても、そのような固定処置自
体が逆に癒着を惹起したり促進する可能性があること
が、本発明者らの検討で明らかになった。したがって、
優れた癒着防止効果を得るためには、生体組織に貼付す
るだけで確実かつ容易に固定できることが必要である。
次に第2の問題は、酸化セルロース膜を生体内に挿入す
ると、短時間で形態が崩れて消失し、必要な期間遮蔽効
果を維持できなくなることである。したがって、酸化セ
ルロース膜よりも長期間形態を維持できることが必要で
あり、数日間程度は形態を保持しその後は速やかに吸収
される材料が好ましいと考えられる。
The materials currently used for such an adhesion preventing method include an oxidized cellulose film and a mixed film of hyaluronic acid and carboxymethyl cellulose, but their effects are extremely insufficient and limited. It is only used in cases that have failed. The present inventors have conducted various studies on the reason why the adhesion preventing effect of the oxidized cellulose film is insufficient, and found that there are two problems described below. That is, the first problem is that the membrane is not sufficiently fixed to the living body and moves from the initial position.
Therefore, the shielding effect is not exerted at a site where adhesion prevention is required. On the other hand, as a method of securely fixing the film, adhesion with an adhesive or suturing with a suture can be considered, but it is difficult to fix the film by these methods because the strength of the oxidized cellulose film is low. Further, even if the fixation can be performed by such a method, it has been revealed by the present inventors that the fixation treatment itself may cause or promote adhesion. Therefore,
In order to obtain an excellent adhesion-preventing effect, it is necessary that the adhesive can be fixed securely and easily simply by sticking it to a living tissue.
Next, the second problem is that when the oxidized cellulose membrane is inserted into a living body, the form collapses and disappears in a short time, and the shielding effect cannot be maintained for a required period. Therefore, it is necessary that the form can be maintained for a longer period of time than the oxidized cellulose membrane, and it is considered that a material that retains the form for about several days and that is quickly absorbed thereafter is preferable.

【0004】尚、化学的(ホルムアルデヒド)に架橋さ
れたゼラチン製癒着防止膜が、アップジョン(UPJO
HN)社よりGel film(登録商標)として市販
されているが、この膜は生体内での分解吸収時間が長
く、また生体内での移動や異物反応の点で有用なものと
はいえなかった。
Incidentally, an adhesion preventing film made of gelatin cross-linked chemically (formaldehyde) is known as UPJO (UPJO).
HN), which is commercially available as Gel film (registered trademark). However, this membrane has a long decomposition and absorption time in a living body, and is not useful in terms of movement in a living body and foreign substance reaction. .

【0005】本発明の目的は、このような機能を持った
癒着防止材を提供することにある。すなわち、生体組織
に確実かつ容易に固定できるようにするために、生体に
対して適度な接着性を持ち、生体組織に簡単に貼付で
き、かつ、数日程度の期間は生体内で形態を保持し、そ
の後は速やかに生体に吸収される癒着防止材を提供する
ことにある。さらに他の目的は、そのような癒着防止材
の製造方法を提供することにある。
An object of the present invention is to provide an adhesion preventing material having such a function. In other words, in order to be able to securely and easily fix to the living tissue, it has appropriate adhesiveness to the living body, can be easily attached to the living tissue, and retains its form in the living body for a period of about several days Then, an object of the present invention is to provide an anti-adhesion material that can be rapidly absorbed by a living body. Still another object is to provide a method for producing such an adhesion preventing material.

【0006】[0006]

【課題を解決するための手段】本発明においては、ゼラ
チンに紫外線を照射して架橋させることによって、上記
の目的を達成した。
In the present invention, the above object has been achieved by irradiating ultraviolet rays to gelatin to crosslink.

【0007】すなわち、本発明は、ゼラチンを成形した
後、さらに紫外線を照射して架橋された癒着防止材に関
する。
That is, the present invention relates to an anti-adhesion material which has been crosslinked by irradiating ultraviolet rays after gelatin has been formed.

【0008】尚、本発明の癒着防止材において、紫外線
を5〜15時間照射して架橋されたものが好ましく、形
態はフィルム状やスポンジ状のものが好ましい。
The anti-adhesion material of the present invention is preferably crosslinked by irradiating ultraviolet rays for 5 to 15 hours, and is preferably in the form of a film or sponge.

【0009】また、本発明の癒着防止材において、含水
率は85〜95重量%の範囲が好ましく、グルコース拡
散係数は4×10-6〜1×10-5cm2/s の範囲が好
ましい。
In the adhesion preventing material of the present invention, the water content is preferably in the range of 85 to 95% by weight, and the glucose diffusion coefficient is preferably in the range of 4 × 10 -6 to 1 × 10 -5 cm 2 / s.

【0010】さらに、本発明は、ゼラチンを成形した
後、さらに紫外線照射による架橋処理を行なうことを特
徴とする癒着防止材の製造方法に関する。
Further, the present invention relates to a method for producing an adhesion preventing material, which comprises subjecting gelatin to a crosslinking treatment by irradiating ultraviolet rays after molding.

【0011】尚、本発明の癒着防止材の製造方法におい
て、紫外線を5〜15時間照射することが好ましい。
In the method for producing an adhesion preventing material according to the present invention, it is preferable to irradiate ultraviolet rays for 5 to 15 hours.

【0012】[0012]

【発明の実施の形態】本発明において使用するゼラチン
としては、通常市販されているゼラチンを使用すること
ができるが、食品用として供給されているものよりも医
療用に提供されているものの方が好ましく、パイロジェ
ンの含有量が少ないものが特に好ましい。
BEST MODE FOR CARRYING OUT THE INVENTION As the gelatin used in the present invention, commercially available gelatin can be used, but those provided for medical use are better than those supplied for food. Those having a low pyrogen content are particularly preferred.

【0013】ゼラチンの成形は、ゼラチンの成形法とし
て公知の方法により行なうことができる。例えばフィル
ム状に成形したい場合は、ゼラチンを水または有機溶媒
に溶解し、ガラス板等の平面上に流延して乾燥させれ
ば、フィルム状の成形物を得ることができる。或いは、
無機塩等の造孔剤をゼラチンに混入した後、造孔剤のみ
を溶解させたり、発泡化して凍結乾燥し、スポンジ状の
成形物を得ることもできる。さらに、上記を組み合わせ
てスポンジ状のシートを成形しても良い。
The molding of gelatin can be carried out by a method known as a method of molding gelatin. For example, when it is desired to form a film, gelatin is dissolved in water or an organic solvent, cast on a flat surface such as a glass plate, and dried to obtain a film-shaped product. Or,
After mixing a pore-forming agent such as an inorganic salt into gelatin, only the pore-forming agent is dissolved or foamed and freeze-dried to obtain a sponge-like molded product. Further, a sponge-like sheet may be formed by combining the above.

【0014】フィルム状の成形物を得た場合に、癒着防
止材としては、10〜300μmの厚みのフィルムとす
ることが好ましい。50〜150μmの厚みのフィルム
がさらに好ましい。薄すぎると破れやすく、逆に厚すぎ
ると硬く、使いにくい。
When a film-shaped molded product is obtained, the adhesion preventing material is preferably a film having a thickness of 10 to 300 μm. More preferred is a film having a thickness of 50 to 150 μm. If it is too thin, it will break easily, and if it is too thick, it will be hard and difficult to use.

【0015】スポンジ状の成形物を得た場合に、癒着防
止材としては、厚み50〜500μm、孔径5μm以下
とすることが好ましい。
When a sponge-like molded product is obtained, the adhesion preventing material preferably has a thickness of 50 to 500 μm and a pore diameter of 5 μm or less.

【0016】得られた成形物は、生体内に挿入すると生
体に吸収されるが、癒着防止材として使用するために
は、これよりもゆっくりと吸収される必要がある。本発
明においては、成形物に紫外線を照射することによりゼ
ラチンを架橋し、生体での分解吸収速度(以下、「吸収
速度」ともいう)を遅くする。後述する図1に示される
ように、吸収速度の低下、すなわち、生体での成形物の
残存の程度は、紫外線の照射量と相関があるので、目標
とする吸収速度になるように照射量を調節すれば良い。
例えば、吸収速度を遅くするために成形物に照射する紫
外線照射量を増加させることもできるし、逆に吸収速度
を速くするために紫外線照射量を減少させることもでき
る。
Although the obtained molded article is absorbed by the living body when inserted into the living body, it must be absorbed more slowly in order to use it as an adhesion preventing material. In the present invention, gelatin is cross-linked by irradiating the molded product with ultraviolet rays, thereby reducing the rate of decomposition and absorption in a living body (hereinafter, also referred to as “absorption rate”). As shown in FIG. 1 to be described later, the decrease in the absorption rate, that is, the degree of remaining of the molded article in the living body is correlated with the irradiation amount of the ultraviolet ray. Just adjust it.
For example, it is possible to increase the amount of ultraviolet irradiation applied to the molded article to reduce the absorption rate, and to decrease the amount of ultraviolet irradiation to increase the absorption rate.

【0017】紫外線照射量としては、特に限定されるも
のではないが、生体内での吸収分解性の点から、例えば
15ワットの紫外線を60cmの距離で5〜15時間照
射することが好ましい。紫外線の照射時間が5時間未満
の場合は、分解が速すぎるため、充分に損傷組織を隔離
できない。逆に15時間を超えると、生体内での吸収分
解が遅くなり、異物反応を引き起こし、かえって癒着を
引き起こす。
The amount of ultraviolet radiation is not particularly limited, but it is preferable to irradiate, for example, 15 watts of ultraviolet radiation at a distance of 60 cm for 5 to 15 hours from the viewpoint of absorption and decomposition in vivo. When the irradiation time of the ultraviolet ray is less than 5 hours, the decomposition is too fast and the damaged tissue cannot be sufficiently isolated. Conversely, if the time exceeds 15 hours, the absorption and decomposition in the living body will be delayed, causing a foreign body reaction and causing adhesion.

【0018】上記のように紫外線処理を行なったゼラチ
ンからなる本発明の癒着防止材は、含水率85〜95重
量%、グルコース拡散係数4×10-6〜1×10-5cm
2/sという性質を有する。
The anti-adhesion material of the present invention comprising gelatin which has been subjected to the ultraviolet treatment as described above has a water content of 85 to 95% by weight and a glucose diffusion coefficient of 4 × 10 -6 to 1 × 10 -5 cm.
It has a property of 2 / s.

【0019】含水率が95重量%を超えると、分解吸収
時間が短くなる(消失が速いと癒着防止効果も低下す
る)。一方、含水率が85重量%未満の場合は、柔軟性
が低下し、生体組織にフィットし難くなるため、癒着防
止効果が低下する。また、含水率が低い場合には、分解
吸収時間が長くなり、体内での滞留時間が長いと生体内
での異物反応が顕著になり、逆に癒着防止の効果は低下
する。
When the water content exceeds 95% by weight, the decomposition and absorption time is shortened (a fast disappearance reduces the adhesion preventing effect). On the other hand, when the water content is less than 85% by weight, the flexibility is reduced and it is difficult to fit the living tissue, so that the adhesion preventing effect is reduced. In addition, when the water content is low, the decomposition and absorption time becomes long, and when the residence time in the body is long, the foreign body reaction in the living body becomes remarkable, and conversely, the effect of preventing adhesion decreases.

【0020】グルコース拡散係数が1×10-5cm2
s を超えると、細胞浸潤や体液成分の透過が昂進し、
癒着防止効果が低下する。一方、グルコース拡散係数が
4×10-6cm2/s 未満の場合は、癒着防止を目的と
する生体部位への栄養透過が低下し、組織修復が遅くな
る。
The glucose diffusion coefficient is 1 × 10 −5 cm 2 /
Beyond s, cell infiltration and permeation of body fluid components increase,
The adhesion prevention effect is reduced. On the other hand, when the glucose diffusion coefficient is less than 4 × 10 −6 cm 2 / s, nutrient permeation to a living body part for the purpose of preventing adhesion is reduced, and tissue repair is delayed.

【0021】また架橋の目的では、紫外線照射以外に熱
処理なども使用することができる。熱処理の温度として
は120〜170℃で処理するのが好ましい。
For the purpose of crosslinking, heat treatment and the like can be used in addition to ultraviolet irradiation. The heat treatment is preferably performed at a temperature of 120 to 170 ° C.

【0022】フィルム状成形物を生体に密着しやすくす
るためには、優れた柔軟性を有することが好ましいが、
グリセリンを添加することにより、成形物の柔軟性を向
上することができる。グリセリンは、成形前にゼラチン
に混合し成形する。グリセリンの添加量は、ゼラチンに
対して50重量%程度までが適当である。
In order to make the film-like molded article easily adhere to the living body, it is preferable to have excellent flexibility.
By adding glycerin, the flexibility of the molded product can be improved. Glycerin is mixed with gelatin before molding and molded. The amount of glycerin to be added is suitably up to about 50% by weight based on gelatin.

【0023】[0023]

【実施例】以下、実施例により本発明をさらに具体的に
説明するが、本発明はこれに限定されるものではない。
尚、以下の例において、「部」は「重量部」であり、癒
着発生率以外の「%」は「重量%」である。
EXAMPLES Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
In the following examples, “parts” are “parts by weight”, and “%” other than the adhesion occurrence rate is “% by weight”.

【0024】[実施例1]ゼラチン(新田ゼラチン製G
0545P)を水に溶解して10%水溶液を調製し、こ
れを撥水処理したガラス板上に流延して乾燥し、厚さ約
100μmのフィルムを得た。殺菌用の紫外線ランプ
(東芝(株)製、GL−15)を使用して、得られたゼ
ラチンフィルムに15ワットの紫外線を60cmの距離
で10、20、40時間照射し(表と裏を半分の時間ず
つ)、以下の癒着防止効果の評価に使用した。尚、比較
品として市販の癒着防止材料も同様に評価に供した。ル
ムを得た。
Example 1 Gelatin (G from Nitta Gelatin)
0545P) was dissolved in water to prepare a 10% aqueous solution, which was cast on a water-repellent glass plate and dried to obtain a film having a thickness of about 100 μm. Using a UV lamp for sterilization (GL-15, manufactured by Toshiba Corp.), the obtained gelatin film was irradiated with 15 watts of ultraviolet light at a distance of 60 cm for 10, 20, and 40 hours (the front and back sides were halved). Each time), and the following evaluation of the adhesion preventing effect was used. As a comparative product, a commercially available anti-adhesion material was similarly evaluated. Got Lum.

【0025】麻酔下で7週齢のWistarラット腹部
を剃毛し、腹部を消毒後、腹部の皮膚および筋組織を正
中線で切開した。腹壁内側の腸骨静脈を切断し、絹糸を
結んで止血した。血管切断部および絹糸を覆うように腹
壁に、酸化エチレンガスにて滅菌した1×1.5cmの
フィルムを貼付して、腹部を縫合した。1週間後に開腹
して、癒着の有無を観察し、癒着防止効果を評価した。
結果は以下の通りである。
Under anesthesia, the abdomen of a 7-week-old Wistar rat was shaved, the abdomen was disinfected, and the skin and muscle tissue of the abdomen were incised at the midline. The iliac vein inside the abdominal wall was cut and tied with silk to stop bleeding. A 1 × 1.5 cm film sterilized with ethylene oxide gas was attached to the abdominal wall so as to cover the cut portion of the blood vessel and the silk thread, and the abdomen was sutured. One week later, the abdomen was opened, the presence or absence of adhesion was observed, and the adhesion preventing effect was evaluated.
The results are as follows.

【0026】 <紫外線照射時間> <癒着発生率(%)> 対照*1 89 0*2 62 10 42 20 77 40 93 Interceed*3 70 Seprafilm*4 83 *1:フィルムを貼付しない。 *2:紫外線照射していないフィルムを貼付する。 *3:Ethicon社製、登録商標。織布(ニット)
を貼付。 *4:Genzyme社製、登録商標。フィルムを貼
付。
<Ultraviolet irradiation time><Adhesion occurrence rate (%)> Control * 1 890 * 2 62 10 42 20 77 40 93 Interceed * 3 70 Seprafilm * 4 83 * 1: No film is attached. * 2: Attach a film that has not been irradiated with ultraviolet light. * 3: Registered trademark of Ethicon. Woven cloth (knit)
Is attached. * 4: Registered trademark of Genzyme. Paste the film.

【0027】上記の結果から明らかなように、紫外線を
10時間照射したフィルムが最も高い癒着防止効果を示
した。紫外線を照射して架橋しないと分解が速すぎるた
め、癒着防止効果が低く、一方20時間以上の紫外線照
射では、分解吸収が遅く、異物反応を誘発し逆に癒着を
引き起こしてしまう。
As is apparent from the above results, the film irradiated with ultraviolet rays for 10 hours showed the highest adhesion preventing effect. Unless crosslinked by irradiation with ultraviolet rays, the decomposition is too fast and the adhesion preventing effect is low. On the other hand, irradiation with ultraviolet rays for 20 hours or more causes slow decomposition and absorption, inducing a foreign substance reaction and consequently causing adhesion.

【0028】[実施例2]殺菌用の紫外線ランプ(東芝
(株)製、GL−15)を使用して、実施例1で得られ
たゼラチンフィルムに15ワットの紫外線を60cmの
距離で5、10、20、40時間照射し(表と裏を半分
の時間ずつ)、以下の生体吸収分解性試験の評価に使用
した。結果は図1に示す通りである。
Example 2 A 15-watt ultraviolet ray was applied to the gelatin film obtained in Example 1 at a distance of 60 cm from the gelatin film obtained in Example 1 using an ultraviolet lamp for sterilization (GL-15, manufactured by Toshiba Corporation). Irradiation was performed for 10, 20, and 40 hours (the front and back sides were halved for each time) and used for the evaluation of the following bioabsorbable degradation test. The results are as shown in FIG.

【0029】フィルム(1×1.5cm)を酸化エチレ
ンガス滅菌し、次のようにして埋入試験を行なった。フ
ィルムの乾燥重量を測定した後、7週齢のWistar
ラットの腹腔内に埋入した。一定期間後にラットを犠牲
死させ、腹腔内からフィルムを摘出した。摘出したフィ
ルムを軽く洗浄し、真空乾燥器を用いて完全に乾燥させ
た後、重量を測定した。フィルムの初期重量と残存重量
との比からゼラチンフィルムの分解性を測定した。
The film (1 × 1.5 cm) was sterilized with ethylene oxide gas and subjected to an embedding test as follows. After measuring the dry weight of the film, 7-week-old Wistar
The rats were implanted intraperitoneally. After a certain period of time, the rats were sacrificed and the film was removed from the peritoneal cavity. The excised film was washed lightly and completely dried using a vacuum dryer, and then weighed. The degradability of the gelatin film was measured from the ratio of the initial weight of the film to the residual weight.

【0030】図1から明らかなように、紫外線を10時
間照射して架橋させたゼラチンフィルムは2日間で分解
し生体に吸収されているため、実施例1にみられるよう
に、優れた癒着防止効果を示したものと考えられる。一
方、紫外線を20時間以上照射して架橋させたゼラチン
フィルムは分解して吸収されるまでに2日以上を要した
ため、低い癒着防止効果を示したものと考えられる。
As is apparent from FIG. 1, the gelatin film cross-linked by irradiating ultraviolet rays for 10 hours is decomposed in 2 days and absorbed by the living body. It is considered that the effect was exhibited. On the other hand, the gelatin film cross-linked by irradiating with ultraviolet rays for 20 hours or more required two days or more to be decomposed and absorbed, and thus it is considered that a low adhesion preventing effect was exhibited.

【0031】図1に示されるように、5〜15時間紫外
線照射されたゼラチンフィルムは1〜7日間程度の生体
分解吸収時間を有するものと推測され、高い癒着防止効
果が期待できる。
As shown in FIG. 1, a gelatin film irradiated with ultraviolet rays for 5 to 15 hours is presumed to have a biodegradation absorption time of about 1 to 7 days, and a high anti-adhesion effect can be expected.

【0032】[実施例3]殺菌用の紫外線ランプ(東芝
(株)製、GL−15)を使用して、実施例1で得られ
たゼラチンフィルムに15ワットの紫外線を60cmの
距離で1、5、10、20、40時間照射し(表と裏を
半分の時間ずつ)、以下に示す方法で含水率を測定し、
結果を図2に示した。
Example 3 A 15-watt ultraviolet ray was applied to the gelatin film obtained in Example 1 at a distance of 60 cm from the gelatin film obtained in Example 1 using an ultraviolet lamp for sterilization (GL-15, manufactured by Toshiba Corporation). Irradiate for 5, 10, 20, 40 hours (half time for front and back), measure water content by the method shown below,
The results are shown in FIG.

【0033】フィルムをリン酸緩衝水溶液(PBS
(−))に25℃で2時間浸漬した後、さらに蒸留水に
25℃で6時間浸漬した。このフィルムの重量を測定
し、湿潤重量とした。その後、このフィルムを真空乾燥
器中で完全に乾燥させ、重量を測定し、乾燥重量とし、
以下の式に従い、含水率を算出した。 含水率(%)=[(湿潤重量−乾燥重量)/湿潤重量]
×100
The film was treated with a phosphate buffer aqueous solution (PBS)
(−)) Was immersed at 25 ° C. for 2 hours, and further immersed in distilled water at 25 ° C. for 6 hours. The weight of this film was measured and defined as the wet weight. Thereafter, the film was completely dried in a vacuum dryer, weighed, and taken as the dry weight,
The water content was calculated according to the following equation. Water content (%) = [(wet weight−dry weight) / wet weight]
× 100

【0034】図2から明らかなように、紫外線を5〜1
5時間照射したゼラチンフィルムは85〜95%の範囲
の含水率を示しており、癒着防止膜として使用する場
合、生体組織に対する追従性(フィット)が優れてい
る。
As is apparent from FIG.
The gelatin film irradiated for 5 hours has a moisture content in the range of 85 to 95%, and when used as an adhesion preventing film, has excellent followability (fit) to living tissue.

【0035】[実施例4]殺菌用の紫外線ランプ(東芝
(株)製、GL−15)を使用して、実施例1で得られ
たゼラチンフィルムに15ワットの紫外線を60cmの
距離で5、10、20、40時間照射し(表と裏を半分
の時間ずつ)、以下に示す方法でグルコース透過性を測
定し、結果を図3に示した。
Example 4 A 15-watt ultraviolet ray was applied to the gelatin film obtained in Example 1 at a distance of 60 cm from the gelatin film obtained in Example 1 using an ultraviolet lamp for sterilization (GL-15, manufactured by Toshiba Corporation). Irradiation was performed for 10, 20, and 40 hours (the front and back sides were halved for each time), and the glucose permeability was measured by the method described below. The results are shown in FIG.

【0036】フィルムをリン酸緩衝水溶液(PBS
(−))に20℃で2時間浸漬した後、2チャンバー拡
散セルを用いてグルコースの透過性を次のようにして評
価した。含水したフィルムをポリエステルメッシュで挟
み、ドナーチャンバーとレセプターチャンバーの間に挿
入した。ドナーチャンバーに10mg/mlに調製した
グルコースのPBS(−)溶液を5ml入れ、レセプタ
ーチャンバーにはPBS(−)溶液を5ml入れた。両
チャンバーを37℃で一定速度で攪拌しつつ、経時的に
レセプターチャンバーより20μlずつ採取し、グルコ
ースB−テストワコー(和光純薬株式会社)を用いてグ
ルコース濃度を測定した。ゼラチンフィルムの拡散係数
は、以下のFickの法則に従う。 ln(1−2CB/C0)=(−2AD/LV)×t
The film was treated with a phosphate buffer aqueous solution (PBS)
After immersion in (−)) at 20 ° C. for 2 hours, glucose permeability was evaluated using a two-chamber diffusion cell as follows. The hydrated film was sandwiched between polyester meshes and inserted between a donor chamber and a receptor chamber. 5 ml of a PBS (-) solution of glucose adjusted to 10 mg / ml was placed in the donor chamber, and 5 ml of a PBS (-) solution was placed in the receptor chamber. While stirring both chambers at a constant speed at 37 ° C., 20 μl was sampled from the receptor chamber over time, and the glucose concentration was measured using Glucose B-Test Wako (Wako Pure Chemical Industries, Ltd.). The diffusion coefficient of a gelatin film obeys the following Fick's law. ln (1-2C B / C 0 ) = (− 2AD / LV) × t

【0037】ここで、CB は、t秒後のレセプターチャ
ンバー中のグルコース濃度(mg/ml)を示す。C0
はドナーチャンバーの初期濃度(mg/ml)を示す。
Aは拡散孔に面したゼラチンフィルムの面積(cm2
、Dはグルコースの拡散係数(cm2/秒) 、Lはゼ
ラチンフィルムの厚さ(cm)、Vはチャンバー内水溶
液の体積(ml)を示す。
[0037] Here, C B represents the glucose concentration in the receptor chamber after t seconds (mg / ml). C 0
Indicates the initial concentration (mg / ml) of the donor chamber.
A is the area of the gelatin film facing the diffusion holes (cm 2 )
, D represents the diffusion coefficient of glucose (cm 2 / sec), L represents the thickness of the gelatin film (cm), and V represents the volume (ml) of the aqueous solution in the chamber.

【0038】時間tに対し、ln(1−2CB/C0)を
プロットしたグラフから、傾きを読取り、拡散係数Dを
算出した。
The slope was read from a graph in which ln (1-2C B / C 0 ) was plotted with respect to time t, and the diffusion coefficient D was calculated.

【0039】図3から明らかなように、5〜15時間紫
外線照射したゼラチンフィルムは好ましいグルコース透
過性を示している。
As is clear from FIG. 3, the gelatin film irradiated with ultraviolet rays for 5 to 15 hours shows preferable glucose permeability.

【0040】[0040]

【発明の効果】本発明の癒着防止材は、生体組織とよく
密着する他、高い含水率及びグルコース透過性を示し、
かつ生体吸収性で適度の吸収速度を有している。
The anti-adhesion material of the present invention exhibits high moisture content and glucose permeability in addition to good adhesion to living tissue,
It is also bioabsorbable and has a moderate absorption rate.

【図面の簡単な説明】[Brief description of the drawings]

【図1】実施例2において、紫外線照射時間を変化させ
た各種ゼラチンフィルムの生体吸収分解性試験の結果を
示すグラフである。
FIG. 1 is a graph showing the results of a bioabsorption degradability test of various gelatin films in which the ultraviolet irradiation time was changed in Example 2.

【図2】実施例3において、紫外線照射時間を変化させ
たゼラチンフィルムの含水率を示すグラフである。
FIG. 2 is a graph showing the water content of a gelatin film obtained by changing the ultraviolet irradiation time in Example 3.

【図3】実施例4において、紫外線照射時間を変化させ
たゼラチンフィルムのグルコース透過性を示すグラフで
ある。
FIG. 3 is a graph showing the glucose permeability of a gelatin film obtained by changing the ultraviolet irradiation time in Example 4.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 松田 晶二郎 京都府綾部市井倉新町石風呂1番地 グン ゼ株式会社京都研究所内 (72)発明者 岩田 博夫 大阪府三島郡島本町若山台1丁目5番地8 −203 (72)発明者 筏 義人 京都府宇治市五ケ庄広岡谷2番地182 Fターム(参考) 4C081 AC03 BA16 BB01 BB04 CB041 CC06 CD151 CE11 DA02 EA03 EA05  ──────────────────────────────────────────────────続 き Continuing from the front page (72) Inventor Shojiro Matsuda 1 Ishishinmachi Ishiburo, Ayabe-shi, Kyoto Gunze Co., Ltd. Kyoto Research Institute (72) Inventor Hiroo Iwata 1-5-5 Wakayamadai, Shimamotocho, Mishima-gun, Osaka Address 8-203 (72) Inventor Yoshito Raft 2-182 Gokasho Hirookadani, Uji City, Kyoto Prefecture F-term (reference) 4C081 AC03 BA16 BB01 BB04 CB041 CC06 CD151 CE11 DA02 EA03 EA05

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 ゼラチンを成形した後、さらに紫外線を
照射して架橋された癒着防止材。
An anti-adhesion material which has been cross-linked by further irradiating ultraviolet rays after forming gelatin.
【請求項2】 紫外線を5〜15時間照射する請求項1
に記載の癒着防止材。
2. The method according to claim 1, wherein the ultraviolet light is irradiated for 5 to 15 hours.
3. The adhesion preventing material according to 1.
【請求項3】 形態がフィルム状である請求項1又は2
に記載の癒着防止材。
3. The method according to claim 1, wherein the form is a film.
3. The adhesion preventing material according to 1.
【請求項4】 形態がスポンジ状である請求項1〜3の
いずれか1項に記載の癒着防止材。
4. The anti-adhesion material according to claim 1, wherein the anti-adhesion material is in the form of a sponge.
【請求項5】 含水率が85〜95重量%である請求項
1〜4のいずれか1項に記載の癒着防止材。
5. The adhesion preventing material according to claim 1, which has a water content of 85 to 95% by weight.
【請求項6】 グルコース拡散係数が4×10-6〜1×
10-5cm2/sである請求項1〜5のいずれか1項に
記載の癒着防止材。
6. A glucose diffusion coefficient of 4 × 10 -6 to 1 ×.
The adhesion preventing material according to any one of claims 1 to 5, wherein the adhesion preventing material is 10 -5 cm 2 / s.
【請求項7】 ゼラチンを成形した後、さらに紫外線照
射による架橋処理を行なうことを特徴とする癒着防止材
の製造方法。
7. A method for producing an adhesion preventing material, which comprises subjecting gelatin to a crosslinking treatment by irradiation with ultraviolet light after molding the gelatin.
【請求項8】 紫外線を5〜15時間照射する請求項7
に記載の癒着防止材の製造方法。
8. Irradiation with ultraviolet rays for 5 to 15 hours.
3. The method for producing an adhesion preventing material according to item 1.
JP20564698A 1998-07-21 1998-07-21 Anti-adhesion material and method for producing the same Expired - Fee Related JP3517358B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20564698A JP3517358B2 (en) 1998-07-21 1998-07-21 Anti-adhesion material and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20564698A JP3517358B2 (en) 1998-07-21 1998-07-21 Anti-adhesion material and method for producing the same

Publications (2)

Publication Number Publication Date
JP2000037450A true JP2000037450A (en) 2000-02-08
JP3517358B2 JP3517358B2 (en) 2004-04-12

Family

ID=16510348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20564698A Expired - Fee Related JP3517358B2 (en) 1998-07-21 1998-07-21 Anti-adhesion material and method for producing the same

Country Status (1)

Country Link
JP (1) JP3517358B2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102428A1 (en) 2001-06-15 2002-12-27 Gunze Limited Synechia inhibitory material
JP2004065780A (en) * 2002-08-08 2004-03-04 Gunze Ltd Biomaterial and antiadhesive material using it
JP2004209228A (en) * 2002-12-16 2004-07-29 Gunze Ltd Film for medical use
US7718556B2 (en) 2002-12-16 2010-05-18 Gunze Limited Medical film
WO2011030829A1 (en) * 2009-09-09 2011-03-17 国立大学法人大阪大学 Structure obtained by crosslinking protein polymer
JP2011160994A (en) * 2010-02-10 2011-08-25 Gunze Ltd Bioabsorbable self-adhesive adhesion preventive material
WO2013018759A1 (en) 2011-08-02 2013-02-07 大日精化工業株式会社 Anti-adhesion medical material and method for producing same
JP2018089370A (en) * 2016-12-05 2018-06-14 グンゼ株式会社 Nerve anti-conglutinate wrapping material
JPWO2021054233A1 (en) * 2019-09-18 2021-03-25
JPWO2021054232A1 (en) * 2019-09-18 2021-03-25
DE112019005432T5 (en) 2018-10-31 2021-07-15 Hi-Lex Corporation NON BIODEGRADABLE ANTIADHESION MATERIAL

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4917775B2 (en) 2005-08-05 2012-04-18 グンゼ株式会社 Method for producing anti-adhesion membrane

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102428A1 (en) 2001-06-15 2002-12-27 Gunze Limited Synechia inhibitory material
US8703627B2 (en) 2001-06-15 2014-04-22 Gunze Limited Antiadhesive material
JP2004065780A (en) * 2002-08-08 2004-03-04 Gunze Ltd Biomaterial and antiadhesive material using it
JP2004209228A (en) * 2002-12-16 2004-07-29 Gunze Ltd Film for medical use
US7718556B2 (en) 2002-12-16 2010-05-18 Gunze Limited Medical film
JP4554916B2 (en) * 2002-12-16 2010-09-29 グンゼ株式会社 Medical film
JP5413786B2 (en) * 2009-09-09 2014-02-12 国立大学法人大阪大学 Cross-linked structure of protein polymer
WO2011030829A1 (en) * 2009-09-09 2011-03-17 国立大学法人大阪大学 Structure obtained by crosslinking protein polymer
JP2011160994A (en) * 2010-02-10 2011-08-25 Gunze Ltd Bioabsorbable self-adhesive adhesion preventive material
WO2013018759A1 (en) 2011-08-02 2013-02-07 大日精化工業株式会社 Anti-adhesion medical material and method for producing same
JP2018089370A (en) * 2016-12-05 2018-06-14 グンゼ株式会社 Nerve anti-conglutinate wrapping material
DE112019005432T5 (en) 2018-10-31 2021-07-15 Hi-Lex Corporation NON BIODEGRADABLE ANTIADHESION MATERIAL
JPWO2021054233A1 (en) * 2019-09-18 2021-03-25
JPWO2021054232A1 (en) * 2019-09-18 2021-03-25
WO2021054233A1 (en) * 2019-09-18 2021-03-25 国立研究開発法人物質・材料研究機構 Biological tissue adhesive sheet , biological tissue reinforcing material kit, and method for producing biological tissue adhesive sheet
WO2021054232A1 (en) * 2019-09-18 2021-03-25 国立研究開発法人物質・材料研究機構 Biological tissue adhesive sheet, biological tissue reinforcing material kit, and method for manufacturing biological tissue adhesive sheet
JP7341533B2 (en) 2019-09-18 2023-09-11 国立研究開発法人物質・材料研究機構 Living tissue adhesive sheet, living tissue reinforcing material kit, and method for producing living tissue adhesive sheet
JP7351545B2 (en) 2019-09-18 2023-09-27 国立研究開発法人物質・材料研究機構 Living tissue adhesive sheet, living tissue reinforcing material kit, and method for producing living tissue adhesive sheet

Also Published As

Publication number Publication date
JP3517358B2 (en) 2004-04-12

Similar Documents

Publication Publication Date Title
US6969523B1 (en) Collagen/glycosaminoglycan matrix stable to sterilizing by electron beam radiation
JP4275204B2 (en) Method for forming oxidized cellulose multilayer film and method for preventing surgical adhesions
CA2521916C (en) Biodegradable film having a honeycomb structure for the prevention of postoperative tissue adhesion
JP3231793B2 (en) Collagen material that can be used especially to prevent post-operative adhesions
EP0044624B1 (en) Lyophilized hydrocolloid foam
JP5047797B2 (en) Non-adhesive elastic gelatin matrix
US5116824A (en) Biomaterial comprising a composite material of a chitosan derivative and collagen derivative
JP3542170B2 (en) Medical material and method for producing the same
JP2000037450A (en) Adhesion preventive material and its manufacture
JP2008509788A (en) Anti-adhesion barrier
EP2083749A2 (en) Flexible bioresorbable hemostatic packing and stent
BRPI0614396A2 (en) anti-adhesion membrane and its production method
JPH06292716A (en) Medical material
JP5003998B2 (en) Adhesion prevention material and adhesion prevention method
JP3502272B2 (en) Biological tissue adhesive medical material and method for producing the same
EP3305339B1 (en) Method for manufacturing collagen film using ultraviolet light, collagen film manufactured by using same, and biomaterial prepared using collagen film
KR20090012439A (en) Hyaluronic acid and carboxymethylcellulose complex derivative film and gel having anti-adhesion property and producing method thereof
WO2017205740A1 (en) Process for preparing tissue regeneration matrix
US20220387662A1 (en) Biological tissue adhesive sheet, biological tissue reinforcement material kit, and method for producing biological tissue adhesive sheet
WO2015049800A1 (en) Bioadhesive medical film
JPH0975442A (en) Cell structure with in vivo decomposing and absorbing function
PL170843B1 (en) Method of obtaining a material for soft tissue integument implants
JP2002000716A (en) Covering material for granulation
PL176000B1 (en) Method of obtaining bicompatible hydrogel membrane for constructing artificial hybrid body organs
MXPA97005746A (en) Material for medical use and procedure to prepare my

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040123

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080130

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090130

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090130

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100130

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100130

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110130

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120130

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130130

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140130

Year of fee payment: 10

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140130

Year of fee payment: 10

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees